Jameshamann4876

Psychiatric patients or settings are excluded from this review.

Two reviewers will independently select and appraise eligible studies and extract data following methods outlined by JBI for systematic reviews of effectiveness. Multiple databases will be searched for studies in English and Chinese from 2008 to the present. The JBI System for the Unified Management, Assessment and Review of Information (SUMARI) will be used to manage studies and, where possible, meta-analysis will be undertaken. Results will be presented in a Summary of Findings following the GRADE approach.

Submitted to PROPSERO June 5, 2020.

Submitted to PROPSERO June 5, 2020.

The objective of this review is to determine the diagnostic accuracy of positive oral contrast versus no oral contrast for common, non-traumatic computed tomography abdominal indications in adults.

Positive oral contrast is regularly administered to patients to drink prior to computed tomography scans of the abdomen and pelvis. The purpose of the preparation is to improve visualization of the bowel, however, technological advances in scanner design may mean positive oral contrast is no longer required.

Eligible studies will consider the use of positive oral contrast in non-traumatic indications for computed tomography of the abdomen and pelvis to include appendicitis, bowel obstruction, diverticulitis, intestinal neoplasms and metastasis (screening or staging), or acute abdomen. The review will use the discharge diagnosis as the reference standard. Studies that describe adult patients (18+) and published from 2000 on will be considered.

MEDLINE Complete, Embase, CINAHL, and Scopus will be searched, along with Google Scholar and numerous radiology college websites. Screening of potential titles and abstracts, retrieval of full-text studies, assessment of methodological quality, and data extraction will be performed independently by two reviewers. Meta-analyses will be performed, if possible, and a Grading of Recommendations, Assessment, Development and Evaluation Summary of Findings presented.

PROSPERO (CRD42020184285).

PROSPERO (CRD42020184285).

The objective of the review is to synthesize the qualitative research literature on the experiences of adults living with multimorbidity.

Persons living with two or more chronic health conditions, known as multimorbidity, is a global health problem in countries of all income levels. Multimorbidity presents an ever-increasing resource and financial burden for health care systems and similarly challenges those living with multiple health conditions because of the complexity of their health and treatment requirements. Overall, persons with multimorbid conditions experience a high risk of mortality and a lower quality of life. Understanding the adult experience of multimorbidity is important for creating and implementing health care that meets the needs of individuals living with the burden of multiple chronic health conditions.

The systematic review will include published peer-reviewed and unpublished English-language studies from 2000 to 2020 that provide qualitative evidence of adults' (18+ years of age) experiences of living with multimorbidity.

CINAHL with full text, Cochrane, MEDLINE, Embase, PsycINFO, Consumer Health Database, Scopus, and ScienceDirect journals and books will be searched. Reference lists of included studies will also be cross-checked with search outcomes to identify additional studies. Sources of gray literature will also be searched for unpublished studies. The critical appraisal of selected studies and the extraction of data will be independently undertaken by two reviewers using JBI methods. The findings will be pooled using meta-aggregation to produce comprehensive synthesized findings. A ConQual Summary of Findings will also be presented.

PROSPERO (CRD42020152038).

PROSPERO (CRD42020152038).

Trust is essential in patient-physician relationships. Hospitalized patients with substance use disorders (SUDs) often experience stigma and trauma in the hospital, which can impede trust. Little research has explored the role of hospital-based addictions care in creating trusting relationships with patients with SUDs. This study describes how trust in physicians changed among hospitalized people with SUDs who were seen by an interprofessional addiction medicine service.

We analyzed data from hospitalized patients with SUD seen by an addiction consult service from 2015 to 2018. Participants completed surveys at baseline and 30 to 90 days after hospital discharge. Follow-up assessments included open-ended questions exploring participant experiences with hospitalization and the addiction consult service. We measured provider trust using the Wake Forest Trust scale. We modeled trust trajectories using discrete mixture modeling, and sampled qualitative interviews from those trust trajectories.

Of 328 particd patients with SUD, and can also mitigate power struggles that hospitalized patients with SUD frequently experience.A subset of ovarian mucinous tumors demonstrates müllerian-type epithelium, with such lesions variably designated "endocervical-like" and seromucinous since their popularization based on a report of borderline examples in 1989. While müllerian mucinous borderline tumors and carcinomas have been highlighted in the literature, there has been minimal attention given to benign müllerian mucinous tumors, particularly müllerian mucinous cystadenomas. Given the paucity of literature describing the features of müllerian mucinous cystadenomas/cystadenofibromas, diagnostic difficulties may arise when papillary features are present and in cases that show a subtle transition from endometriosis. this website We thus reviewed 25 cases of müllerian mucinous cystadenoma/cystadenofibroma to highlight the notable characteristics of this entity, including gross, cytologic, and architectural features that aid in the distinction from müllerian mucinous borderline tumors as well as, rarely, metastatic tumors. The patients ranged in age from 26inous cystadenoma" due to the frequent association with endometriosis as well as the dominant mucinous epithelium.